Hematologic Malignancies

Hematologic Malignancies

Methylphenidate May Reduce Cancer-Related Fatigue in Patients With Hematologic Malignancies

November 9 3 min read
Treatment with methylphenidate significantly reduced cancer-related fatigue in patients with hematologic malignancies compared with placebo, according to findings from the randomized, double-blind, crossover MICRO trial reported by Frederiksen et al in the Journal of Clinical Oncology. The improvement exceeded the prespecified threshold for clinical relevance, and treatment was generally well tolerated.

Latest in Hematologic Malignancies